Exact Mass: 395.9571748
Exact Mass Matches: 395.9571748
Found 70 metabolites which its exact mass value is equals to given mass value 395.9571748
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Sulconazole
C18H15Cl3N2S (396.00214800000003)
D - Dermatologicals > D01 - Antifungals for dermatological use > D01A - Antifungals for topical use > D01AC - Imidazole and triazole derivatives D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent
Ethiprole
5,5'-Dithiobis(2-nitrobenzoic acid)
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D013439 - Sulfhydryl Reagents
2,10-Dibromo-3-chloro-alpha-chamigrene
C15H23Br2Cl (395.98549080000004)
DTNB
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D013439 - Sulfhydryl Reagents
2-Amino-3-methyl-5-[(5,6-dibromo-1H-indole-3-yl)methylene]-1-imidazoline-4-one
O1-(2-iodo-phenyl)-beta-D-glucopyranuronic acid|O1-(2-Jod-phenyl)-beta-D-glucopyranuronsaeure
3,8-dibromo-7-O-methylchlamydosporol|bromomethylchlamydosporol B
C12H14Br2O5 (395.92079140000004)
4-Iodophenol glucuronide|O1-(4-iodo-phenyl)-beta-D-glucopyranuronic acid|O1-(4-Jod-phenyl)-beta-D-glucopyranuronsaeure
3-amino-N-[3-oxo-2-(2,4,6-trichlorophenyl)-1H-pyrazol-5-yl]benzamide
C16H11Cl3N4O2 (395.99475559999996)
3-Amino-N-(5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazol-3-yl)benzamide
C16H11Cl3N4O2 (395.99475559999996)
D-Fructose, 1-(dihydrogen phosphate), barium salt (1:1)
C6H11BaO9P (395.91930460000003)
6-Iodo-1-(4-methoxybenzyl)-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one
7-Iodo-1-(4-methoxybenzyl)-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one
4-iodo-N-(2-morpholin-4-ylethyl)benzenesulfonamide
[6-O-Phosphono-κ2O,Ohexopyranosato(2-)]barium
C6H11BaO9P (395.91930460000003)
d-fructose-6-phosphate barium salt
C6H11BaO9P (395.91930460000003)
3-[(E)-3-anilino-3-oxoprop-1-enyl]-4,6-dichloro-1H-indole-2-carboxylic acid
C18H11Cl2N2NaO3 (396.00443960000007)
2-Bromo-N-[2-(2-chlorobenzoyl)-4-nitrophenyl]acetamide
C15H10BrClN2O4 (395.95124300000003)
2,3,3,4,4,5,5,6,6,7,7,8,8,8-Tetradecafluorooctanoic acid
2-Amino-4-(2-chlorophenyl)-6-[(4-chlorophenyl)thio]pyridine-3,5-dicarbonitrile
C19H10Cl2N4S (396.00032000000004)
1-[(7-Chloro-4-quinolinyl)amino]-3-(2,4-dichlorophenyl)thiourea
2-[(5-chloro-2-thiophenyl)sulfonylamino]-N-(2-furanylmethyl)benzamide
C16H13ClN2O4S2 (396.00052480000005)
2-Bromo-1-(4-methoxyphenyl)-3-[(4-methylphenyl)sulfonyl]-1-propanone
C17H17BrO4S (396.00308620000004)
1-(5-Bromo-2-thiophenyl)-2-[(5-methoxy-1-methyl-2-benzimidazolyl)thio]ethanone
[[Hydroxy(oxido)amino]oxy-nitrooxybismuthanyl] nitrate
sulconazole
C18H15Cl3N2S (396.00214800000003)
D - Dermatologicals > D01 - Antifungals for dermatological use > D01A - Antifungals for topical use > D01AC - Imidazole and triazole derivatives D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent
Gavestinel (sodium salt)
C18H11Cl2N2NaO3 (396.00443960000007)
Gavestinel (GV 150526A) is a potent, selective, orally active and non-competitive antagonist of NMDA receptor. Gavestinel binds to the glycine site of the NMDA receptor, with a pKi of 8.5. Gavestinel can be used for the research of acute ischemic stroke[1].
(4s,6r,8r,9r)-4,8-dibromo-9-chloro-1,5,5,9-tetramethylspiro[5.5]undec-1-ene
C15H23Br2Cl (395.98549080000004)
4,8-dibromo-9-chloro-1,5,5,9-tetramethylspiro[5.5]undec-1-ene
C15H23Br2Cl (395.98549080000004)
(5z)-5-[(5,6-dibromo-1h-indol-3-yl)methylidene]-2-imino-3-methylimidazolidin-4-one
{7,13-dihydroxy-14-methoxy-3,10-dioxo-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(15),4,6,8(16),11,13-hexaen-6-yl}oxidanesulfonic acid
{13,14-dihydroxy-7-methoxy-3,10-dioxo-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(15),4,6,8(16),11,13-hexaen-6-yl}oxidanesulfonic acid
(2r,6s)-2,8-dibromo-9-chloro-1,1,9-trimethyl-5-methylidenespiro[5.5]undecane
C15H23Br2Cl (395.98549080000004)
(2r,6s,8s,9s)-2,8-dibromo-9-chloro-1,1,9-trimethyl-5-methylidenespiro[5.5]undecane
C15H23Br2Cl (395.98549080000004)
(4s,6s,8s,9s)-4,8-dibromo-9-chloro-1,5,5,9-tetramethylspiro[5.5]undec-1-ene
C15H23Br2Cl (395.98549080000004)
5-[(5,6-dibromo-1h-indol-3-yl)methylidene]-2-imino-3-methylimidazolidin-4-one
(4r,6s)-4,8-dibromo-9-chloro-1,5,5,9-tetramethylspiro[5.5]undec-1-ene
C15H23Br2Cl (395.98549080000004)
(2s,6s,8s,9s)-2,8-dibromo-9-chloro-1,1,9-trimethyl-5-methylidenespiro[5.5]undecane
C15H23Br2Cl (395.98549080000004)
4,9-dibromo-8-chloro-1,5,5,9-tetramethylspiro[5.5]undec-1-ene
C15H23Br2Cl (395.98549080000004)
(2s,6s)-2,9-dibromo-8-chloro-1,1,9-trimethyl-5-methylidenespiro[5.5]undecane
C15H23Br2Cl (395.98549080000004)
(4r,6s,8s,9s)-4,9-dibromo-8-chloro-1,5,5,9-tetramethylspiro[5.5]undec-1-ene
C15H23Br2Cl (395.98549080000004)
2,8-dibromo-9-chloro-1,1,9-trimethyl-5-methylidenespiro[5.5]undecane
C15H23Br2Cl (395.98549080000004)
(2s,6r,8r,9r)-2,9-dibromo-8-chloro-1,1,9-trimethyl-5-methylidenespiro[5.5]undecane
C15H23Br2Cl (395.98549080000004)
(2s,6s,8r,9r)-2,9-dibromo-8-chloro-1,1,9-trimethyl-5-methylidenespiro[5.5]undecane
C15H23Br2Cl (395.98549080000004)
(2r,6s,8r,9r)-2,9-dibromo-8-chloro-1,1,9-trimethyl-5-methylidenespiro[5.5]undecane
C15H23Br2Cl (395.98549080000004)
(7r)-3,8-dibromo-4,7-dimethoxy-7,8-dimethyl-5h-pyrano[3,2-c]pyran-2-one
C12H14Br2O5 (395.92079140000004)
(7r,8s)-3,8-dibromo-4,7-dimethoxy-7,8-dimethyl-5h-pyrano[3,2-c]pyran-2-one
C12H14Br2O5 (395.92079140000004)
(5e)-5-[(5,6-dibromo-1h-indol-3-yl)methylidene]-2-imino-3-methylimidazolidin-4-one
(2r,6s)-2,9-dibromo-8-chloro-1,1,9-trimethyl-5-methylidenespiro[5.5]undecane
C15H23Br2Cl (395.98549080000004)
2,9-dibromo-8-chloro-1,1,9-trimethyl-5-methylidenespiro[5.5]undecane
C15H23Br2Cl (395.98549080000004)
(6s)-2,9-dibromo-8-chloro-1,1,9-trimethyl-5-methylidenespiro[5.5]undecane
C15H23Br2Cl (395.98549080000004)
(2r,6s,8s,9s)-2,9-dibromo-8-chloro-1,1,9-trimethyl-5-methylidenespiro[5.5]undecane
C15H23Br2Cl (395.98549080000004)
(4r,6s,8s,9s)-4,8-dibromo-9-chloro-1,5,5,9-tetramethylspiro[5.5]undec-1-ene
C15H23Br2Cl (395.98549080000004)